Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 105 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Post Myocardial Infarction Clear all

Conditions: Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction
Interventions: MyoCell™, MyoCath™; Drug · Device
Lead sponsor: Bioheart, Inc.; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 5
States / cities: Sunrise, Florida • Atlanta, Georgia • Minneapolis, Minnesota + 2 more

Conditions: Cardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Death, Sudden, Cardiac, Ventricular Arrhythmia
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 715 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1988 – 1993
U.S. locations: 1
States / cities: New York, New York

Conditions: ST Segment Elevation Acute Myocardial Infarction
Interventions: Anakinra, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Cardiovascular Events, MACE
Interventions: Tezepelumab; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 12 Years to 130 Years
Enrollment: 16,640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Coronary Artery Disease, Death, Myocardial Infarction
Interventions: Not listed
Lead sponsor: VA Boston Healthcare System; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: West Roxbury, Massachusetts

Conditions: Anterior Acute Myocardial Infarction (AMI)
Interventions: Supersaturated O2 Therapy of the Therox Downstream System®, PCI alone; Device · Procedure
Lead sponsor: TherOx; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Charleston, West Virginia • Huntington, West Virginia

Conditions: Myocardial Inflammation, Myocardial Infarction
Interventions: Change in Soluble MER Concentration; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: Up to 19 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Myocardial Infarction
Interventions: Aliskiren, placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 820 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Novartis US, New Jersey

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cardiogenic Shock, STEMI
Interventions: SSO2 Downstream System, PCI + Impella; Device · Procedure
Lead sponsor: TherOx; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 7
States / cities: Miami, Florida • Springfield, Massachusetts • Detroit, Michigan + 4 more

Conditions: Atherosclerosis
Interventions: Canakinumab, Placebo, Standard of care; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 10,066 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 315
States / cities: Athens, Alabama • Birmingham, Alabama • Fairhope, Alabama + 248 more

Conditions: Acute Myocardial Infarction, STEMI
Interventions: TherOx DownStream System, PCI; Device
Lead sponsor: TherOx; Industry
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Interventions: CD-NP; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Myocardial Infarction, Acute, Myocardial Infarction
Interventions: Financial Incentive and Mobile Phone App; Behavioral
Lead sponsor: Wellth Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Myocardial Infarction, Heart Failure
Interventions: Anakinra, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Respiratory Failure, Respiratory Arrest, Respiratory Distress Syndrome, Acute Respiratory Failure, Acute Respiratory Failure With Hypoxia, Acute Respiratory Failure With Hypercapnia, Acute Respiratory Failure Post Surgical, Acute Respiratory Failure Postprocedural, Acute Respiratory Failure Following Trauma and Surgery, Acute Respiratory Failure Requiring Reintubation, Acute Respiratory Failure Post Traumatic, Acute Respiratory Decompensation, Shock, Shock, Septic, Shock, Cardiogenic, Acute Cardiac Failure, Multi Organ Failure, Acute Kidney Failure
Interventions: Observational retrospective cohort to describe data validity; and Data reliability; and Completeness of the data; Other
Lead sponsor: Efficacy Care R&D Ltd; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 50,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Coronary Artery Disease, Acute Myocardial Infarction
Interventions: Enoxaparin; Drug
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 6
States / cities: Denver, Colorado • Royal Oak, Michigan • Syracuse, New York + 3 more

Conditions: Myocardial Infarction
Interventions: Stress Challenge; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Acute Myocardial Infarction
Interventions: LCZ696 (sacubitril/valsartan), Ramipril, Placebo of LCZ696, Placebo of ramipril, Valsartan, Placebo of valsartan; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 5,669 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 81
States / cities: Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 74 more

Conditions: Acute Coronary Syndrome
Interventions: Losmapimod 7.5 mg twice daily, Placebo twice daily, Standard therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 35 Years and older
Enrollment: 3,503 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 91
States / cities: Huntsville, Alabama • Cottonwood, Arizona • Tucson, Arizona + 83 more

Conditions: Hyperoxia, Myocardial Infarction, Myocardial Injury
Interventions: Inspiratory oxygen fraction; Drug
Lead sponsor: University Hospital Bispebjerg and Frederiksberg; Other
Eligibility: 18 Years and older
Enrollment: 7,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stable Coronary Artery Disease (CAD), Myocardial Infarction
Interventions: Not listed
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years and older
Enrollment: 9,284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 34
States / cities: Huntsville, Alabama • Los Angeles, California • Santa Ana, California + 31 more

Conditions: Acute Kidney Injury, Renal Insufficiency, Chronic, Heart Failure, Myocardial Infarction, Arrhythmias, Cardiac, Stroke
Interventions: Transcatheter Aortic Valve Replacement; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 3
States / cities: Dallas, Texas

Conditions: Acute ST Segment Elevation Myocardial Infarction, Acute Coronary Syndrome
Interventions: Ticagrelor, Clopidogrel; Drug
Lead sponsor: Medical Center of South Arkansas; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: El Dorado, Arkansas

Search by objective public record fields.

MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)

Heart Rate Variability and Sudden Cardiac Death

Anakinra to Prevent Post-infarction Remodeling

Tezspire Cardiac Events PASS

Long-term Outcomes of Patients After Coronary Bifurcation Stenting

A Prospective Real-World Multi-Center Post-Market Observational Evaluation of Supersaturated O2 Therapy Using the TherOx® Downstream® System

Mer-TK in Human Cardiac Cells

Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction

Incorporating Supersaturated Oxygen in Shock

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function

A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence

Anakinra to Prevent Adverse Post-infarction Remodeling (2)

Postoperative Respiratory Abnormalities

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Intraoperative Hyperoxia and MINS

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis